There are two ways to upgrade a human - tinker with biology or augment with technology. So when the time comes to upgrade to human 2.0, should we become Bioshock-style splicers or Halo-esque spartans?
This week we look at the science behind a genetic boost.
Science fiction isnt afraid to mess with genetics. Bioshocks ADAM is a syrup of stem cells augmented with plasmids that carry superhuman genetic traits. Preys Neuromod enhances cognitive abilities by splicing alien genetics into viruses delivered directly into the brain through the eyes. And Prototype's Blacklight gets in to cells and tweaks their genetic code, activating and editing dormant sequences.
So how close are we to game-changing genetic upgrades?
(Image: I.C. Baianu et al.)
The genetic revolution started in the 1950s with two wily Cambridge scientists. With data nabbed from colleagues in London, Watson and Crick deciphered the structure of DNA and opened Pandoras box. Since then, the field has moved fast, and it's littered with Nobel Prizes.
By the mid 1970s, scientists had discovered DNA-snipping molecular scissors known as restriction enzymes, and DNA-stitching enzymes called ligases. It became possible to cut and splice the genetic code, stitching components from different organisms to create recombinant DNA.Bacteria were turned into factories, churning out molecules that they were never intended to make, and genetic engineering began in ernest.
(Image: Bethesda)
In the 1980s, everything sped up. Polymerase chain reaction (PCR) was invented, allowing chunks of DNA to be copied millions of times in a matter of hours. And DNA sequencing became automated, enabling the genetic code to be read faster than ever before.
And the next logical step once you can read the genetic code? Read all of it.
In 2003, the Human Genome Project was completed , revealing the recipe for a human in its entirety. All three billion letters and over 20,000 genes. And, what took an international team decades can now be repeated in days.
We've got the manual to make a human being. We have the tools to read, write and edit DNA. Time to get creative.
(Image: Irrational Games/2K Games)
Interested in making fire with your fingers? Bioshock-style plasmids are already here. Every day scientists stuff them with genes and jam them into cells to give them new abilities.
Real-world plasmids are loops of DNA most often found in bacteria, where they carry genes for useful traits like antibiotic resistance. They replicate independently of the main bacterial genetic code and can be swapped between cells like trading cards that upgrade the microbes' abilities.
And, with a molecular toolkit, they can be cut open and edited, carrying thousands of letters of genetic code like miniature trojan horses.
(Image: Minestrone Soup )
Plasmids can force cells to make new molecules or switch the behaviour of their existing genes. Bacteria will make infinite copies of them on demand. And, they can be frozen down and stored for years.
But, they tend stay out of chromosomes, floating about in the cell and never meshing with the host unless some serious selective pressure is applied.
They're good for a temporary upgrade, but maybe not for a permanent human 2.0 changes. Maybe thats why splicers need a constant ADAM or EVE fix to keep their abilities topped up.
(Image: 2K Games)
Looking for something a little more permanent than a plasmid? Augments in Prey are delivered by viruses, a step up in terms of persistence.
Retroviruses (like HIV) stitch their own genetic code into the code of the cells they infect, permanently merging with their host to ensure that their genes remain active generation after generation. Every time the cell copies its own DNA, it copies the viral genes too.
So, scientists stripped them out, snipping away the genes that cause disease and turning them into empty genetic transport vessels.
(Image: Bethesda Softworks)
Like plasmids, these 'viral vectors' can be stuffed with genetic code, but this time theyll stitch the new genes straight into the cell, adding the new trait permanently. This is the tech is used in Prey to deliver alien genetics into human brains.
Trouble is, viruses aren't that picky about where they choose to integrate. And, if they tuck their DNA right in the middle of something important, they can ruin a crucial gene and destroy the cell they've infected. Worse still, inserting into some genes can cause cancer.
Then there's the problem of getting them to infect the right cells. If you want fire at your fingertips, you'd need a virus that knew the difference between a hand and a foot.
Scientists are working on improving the usability of viral vectors, but to achieve true human 2.0 without the unpredictable side effects, we'll probably need a more targeted approach. Enter CRISPR.
(Image: Thomas Splettstoesser)
Bioshock or Prey-style approaches to gene editing work well, but they're fuzzy and they take time. CRISPR delivers precision genetic manipulation, fast.
Here's how it works.
Viruses, known as bacteriophages, inject their genetic code into bacteria, turning the microbes into miniature virus factories. But the bacteria evolved a way to fight back.
When they come under attack, they store strips of viral genetic code in a CRISPR reference library so that they'll have a head start if the virus returns. When it attacks again, they check the library and an enzyme called Cas9 chops out any matching code, stopping the infection in its tracks.
(Image: National Human Genome Research Institute (NHGRI) from Bethesda, MD, USA)
The great thing about CRISPR is that it's programmable. Give Cas9 a 20-letter strip of genetic code to guide it, and it'll chew up any DNA you want. These are quick and cheap to make in the lab, and the sequence can be made to match all kinds of different genes. And, when the cell goes to repair the cut, you can swoop in with any new DNA you want to add.
The technique has the scientific community so excited that it was named 'breakthrough of the year' by Science in 2015. But is the world about to be overrun with splicers?
(Image: Ingrid Moen et al. 2012)
Splicers can make fire with their hands, hurl balls of ice and cling to the ceiling like spiders. Morgan Yu can morph into a cup, superheat plasma and create telekinetic shields. What could we do with CRISPR at our disposal?
So far, scientists have repaired a gene that causes muscular dystrophy in mice, and they're trialling the technique to reprogram immune cells in people with cancer. We're now in a CRISPR arms race as scientists across the world rush to be the first to make a gene editing breakthrough.
(Image: Bethesda)
It's early days, but the tech has a lot of potential. We could edit single letter mistakes in genetic code, switch genes off, turn genes on, make genetic tweaks. Or, best of all, we could borrow genes from other species and smash them into our cells to acquire traits we were never supposed to have, glow in the dark jellyfish genes, anyone?
In 2010, scientists created the first synthetic cell. In 2016, they designed and built a genome. In the future, it's possible that we could design brand new genes of our own.
Let's face it, this is still a dream, but the toolkit to make it happen is there.
We still don't know what all of our DNA is for, let alone what changes we'd need to make to improve it. Good luck finding the right genes to edit if you're looking to make yourself taller, smarter or funnier, let alone inventing one that'll give you wings.
And then there's the issue of inheritance. Editing adult, or 'somatic', cells could change a person Bioshock-style, but editing sperm and eggs, or 'germline' cells, could change a whole species.
At the moment, genetic engineering tech is moving faster than the regulation to control it, and it's got scientists worried. We all saw what happened to Rapture when the brakes were taken off scientific advancement.
Gene editing germline cells is restricted in many countries, including the UK, but in July 2017, Chinese scientists got CRISPR working in human embryos for the first time. It was a huge breakthrough, but out of 86 embryos only 28 were successfully edited, and not all of them ended up with the right gene mod at the end.
Rapture, a city where the artist would not fear the censor, where the scientist would not be bound by petty morality, Where the great would not be constrained by the small! And with the sweat of your brow, Rapture can become your city as well.
Luckily, no-one is trying to take edited human embryos all the way though to birth, yet. But, CRISPR opens a whole can of ethical worms, and if youre in any doubt that human modification is coming, watch this.
Pandora's box is open, and we're betting humans of the future will be genetically augmented, but it isn't the only way our species could upgrade. Come back next week when we'll be looking at tech and what it'd take to join the ranks of Halo's Master Chief or Deus Ex's Adam Jensen.
Originally posted here:
Genetic engineering: upgrading to human 2.0 - T3
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- 5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021